Showing results (531-540 of 734) with videos related to

Sort By:
Pageof 74
Molecular Therapy. Nucleic Acids|December 19, 2013
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid NanoparticlesBarbara L Mui, Ying K Tam, Muthusamy Jayaraman, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2018
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed LymphomaLeslie Padrnos, Brenda Ernst, Amylou C Dueck, et al.
American Journal of Hematology|March 27, 2026
High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma SubtypesArushi Khurana, Hikaru Hayashi, Bethany Thach, et al.
Targeted Oncology|October 23, 2021
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL StudyEliza A Hawkes, Tycel Phillips, Lihua Elizabeth Budde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2017
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid TumorsHoward A Burris, Jeffrey R Infante, Stephen M Ansell, et al.
American Journal of Clinical Pathology|June 6, 2018
Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?Hong Fang, Prashant Kapoor, Wilson I Gonsalves, et al.
British Journal of Haematology|December 3, 2015
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trialRanjana H Advani, Stephen M Ansell, Mary J Lechowicz, et al.
The American Journal of Surgical Pathology|May 16, 2018
PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal RelatednessRong He, Wei Ding, David S Viswanatha, et al.
BMC Cancer|May 25, 2011
The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancerJames F Grutsch, Carol Ferrans, Patricia A Wood, et al.
Blood|October 28, 2017
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trialNancy L Bartlett, Brian A Costello, Betsy R LaPlant, et al.
Pageof 74